Nurse AMIE for Cancer

Phase-Based Progress Estimates
CancerNurse AMIE - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether an electronic symptom management system can help people with stage 3 and 4 cancer live longer, specifically those who live in rural areas.

Eligible Conditions
  • Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: through study completion, an average of two years

Month 24
Change in Symptoms measured using the Patient-Reported Outcomes Measurement Information System: The PROMIS ®-Preference (PROPr)
Month 24
Change in Health-Related Quality of Life measured using the 36-Item Short Form Health Survey (SF-36)
Change in Physical Function measured using the Short Physical Performance Battery (SPPB)
month 24
Cost-Effectiveness measured using a self-report survey of Healthcare Utilization
through study completion, an average of two years

Trial Safety

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Nurse AMIE Supportive Care Intervention
1 of 2

Active Control

Experimental Treatment

344 Total Participants · 2 Treatment Groups

Primary Treatment: Nurse AMIE · No Placebo Group · N/A

Nurse AMIE Supportive Care Intervention
Experimental Group · 1 Intervention: Nurse AMIE · Intervention Types: Behavioral
Usual Care
ActiveComparator Group · 1 Intervention: Usual Care · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Nurse AMIE

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of two years

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
461 Previous Clinical Trials
2,784,237 Total Patients Enrolled
West Virginia UniversityOTHER
161 Previous Clinical Trials
50,093 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,092 Previous Clinical Trials
41,142,416 Total Patients Enrolled
Mount Nittany Medical CenterUNKNOWN
Kathryn Schmitz, PhDPrincipal InvestigatorPenn State College of Medicine
10 Previous Clinical Trials
1,406 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are 18 years of age or older.
You are receiving pharmacologic treatment, for the purpose of treating your cancer (i.e.
You live in a county with RUCC code 4 to 9 and/or zip code with RUCA code 4-10.
You have access to a personal device capable of receiving telephone calls for study facilitator check-ins.